From the World Economic Forum Davos Agenda:

With 9.9 million new cases of dementia globally each year, the type of collective action witnessed during the COVID-19 pandemic is urgently needed.

What policies, practices and partnerships can help to develop new diagnostics and treatments for Alzheimer’s?

This session is associated with the Davos Alzheimer's Collaborative, convened by the Global CEO Initiative (CEOi) and the World Economic Forum.

Speakers:

Ali Velshi, Anchor, NBC News

Michel Vounatsos, Chief Executive Officer, Biogen

Jeff Huber, Chief Executive Officer, Home Instead Inc.

​Amy Goldman, Chief Executive Officer and Chair, GHR Foundation

GHR Foundation is joining forces with industry, other philanthropic partners and the United States National Institutes of Health on a game-changing undertaking – the prevention of Alzheimer’s disease. One important study GHR is supporting is The Mayo Clinic Study of Aging, which is working to define the impact of Alzheimer's on the population and develop a screening approach to identify those at risk.

View a case study on The Mayo Clinic's innovative research by clicking image below.

GHR supports innovative new approaches to address the impact of Alzheimer’s disease. If you are interested in learning more about GHR’s Health Initiative, contact us.